Related references
Note: Only part of the references are listed.Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
Jiaxing Wang et al.
DRUG DISCOVERY TODAY (2022)
In Silico-Guided Rational Drug Design and Semi-synthesis of C(2)-Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitors
Shisanupong Anukanon et al.
ACS OMEGA (2021)
Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding
H. T. Henry Chan et al.
CHEMICAL SCIENCE (2021)
Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR Analysis
Yasmin M. Syam et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer
Shweta Shyam Prassanawar et al.
BIOCHEMICAL JOURNAL (2019)
A tetrapeptide class of biased analgesics from an Australian fungus targets the μ-opioid receptor
Zoltan Dekan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Anti-mitotic therapies in cancer
Julia Tischer et al.
JOURNAL OF CELL BIOLOGY (2019)
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
Sarah A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Mitochondrial and caspase pathways are involved in the induction of apoptosis by nardosinen in MCF-7 breast cancer cell line
Amirhosein Shahali et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2018)
Insights into Thiol-Aromatic Interactions: A Stereoelectronic Basis for S-H/π Interactions
Christina R. Forbes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Computer-aided identification of novel anticancer compounds with a possible dual HER1/HER2 inhibition mechanism
Samia A. Elseginy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site
Dong-Dong Li et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma
Veronique Martel-Frachet et al.
ONCOTARGET (2015)
High performance in silico virtual drug screening on many-core processors
Simon McIntosh-Smith et al.
INTERNATIONAL JOURNAL OF HIGH PERFORMANCE COMPUTING APPLICATIONS (2015)
Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
Jessica J. Field et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Novel Colchicine-Site Binders with a Cyclohexanedione Scaffold Identified through a Ligand-Based Virtual Screening Approach
Maria-Dolores Canela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Cellular Mechanisms Controlling Caspase Activation and Function
Amanda B. Parrish et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The Tubulin Colchicine Domain: a Molecular Modeling Perspective
Alberto Massarotti et al.
CHEMMEDCHEM (2012)
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Yan Lu et al.
PHARMACEUTICAL RESEARCH (2012)
Three-component condensation of 5-aminoimidazole derivatives with aldehydes and Meldrum's acid. Synthesis of 3,4,6,7-tetrahydroimidazo[4,5-b]pyridin-5-ones
B. V. Lichitsky et al.
RUSSIAN CHEMICAL BULLETIN (2012)
Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency
Han Wang et al.
JOURNAL OF CHEMICAL PHYSICS (2010)
Human Mutations That Confer Paclitaxel Resistance
Shanghua Yin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Tubulin modifications and their cellular functions
Jennetta W. Hammond et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility
Modest von Korff et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Molecular basis for resistance of Acanthamoeba tubulins to all major classes of antitubulin compounds
Fiona L. Henriquez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
How do microtubule-targeted drugs work? An overview
Mary Ann Jordan et al.
CURRENT CANCER DRUG TARGETS (2007)
Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole
Susan L. Mooberry et al.
MOLECULAR PHARMACOLOGY (2007)
Vascular disrupting agents
John W. Lippert
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Antitubulin agents for the treatment of cancer - a medicinal chemistry update
Neeraj Mahindroo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Structural intermediates in microtubule assembly and disassembly: how and why?
E Nogales et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
TL Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Share Paper
